Union Bancaire Privee UBP SA Has $13.93 Million Stake in Danaher Corporation $DHR

Union Bancaire Privee UBP SA raised its stake in Danaher Corporation (NYSE:DHR) by 1,677.5% in the fourth quarter, Holdings Channel reports. The fund owned 65,662 shares of the conglomerate’s stock after purchasing an additional 61,968 shares during the quarter. Union Bancaire Privee UBP SA’s holdings in Danaher were worth $13,929,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in DHR. JPL Wealth Management LLC bought a new position in Danaher in the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the second quarter worth $26,000. Howard Hughes Medical Institute acquired a new position in shares of Danaher during the second quarter worth $27,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher in the 3rd quarter valued at $27,000. Finally, TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the 3rd quarter valued at $28,000. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on DHR. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research report on Monday, December 29th. Robert W. Baird set a $251.00 price target on Danaher in a research note on Thursday, January 29th. JPMorgan Chase & Co. lifted their price target on Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, January 29th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Finally, Evercore reiterated an “outperform” rating and issued a $254.00 price objective on shares of Danaher in a report on Wednesday, January 28th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $253.55.

Danaher Stock Performance

Shares of DHR stock opened at $190.42 on Friday. The stock has a market capitalization of $134.66 billion, a PE ratio of 37.78, a PEG ratio of 2.60 and a beta of 0.93. The business’s 50 day simple moving average is $215.31 and its 200 day simple moving average is $214.96. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the business earned $2.14 EPS. As a group, research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a dividend of $0.40 per share. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s payout ratio is 25.40%.

Insider Transactions at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.